Clinical Trial Update: Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis [Phase 2]

View source ↗

Summary

This clinical trial update reports on the Phase 2 study evaluating safety, tolerability, and efficacy of saroglitazar magnesium in patients with Primary Biliary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Saroglitazar Magnesium (saroglitazar magnesium)

Snippet

Sponsor: Zydus Therapeutics Inc. | Conditions: Primary Biliary Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19